Community post

Qeen Biotechnologies (in partnership with Cellexus, CPI, University of Exeter, NRC Canada, and Unity Health Toronto) was awarded a $2M CAD grant through the Canada–UK: Biomanufacturing of Biologics and Advanced Therapies program to develop a scalable GMP manufacturing platform for phage therapies.